The Journal of Immunology, Vol 155, Issue 4 1776-1783, Copyright © 1995 by American Association of Immunologists

ARTICLES

Activated T cells can induce high levels of CTLA-4 expression on B cells

HM Kuiper, M Brouwer, PS Linsley and RA van Lier
Central Laboratory, The Netherlands Red Cross Blood Transfusion Service, Amsterdam.

Engagement of the TCR/CD3 complex together with ligation of CD28 by its counterstructures B7-1 (CD80) and B7-2 (CD86) on APC are required for mitogenic T cell activation. After activation, T cells not only express B7-1 and B7-2 molecules, but a second receptor for the B7 ligands, CTLA- 4, can be found on their surfaces. We here show that B cells can be induced to express CTLA-4 on the plasma membrane. Similar to what has been reported for T cells, CTLA-4 expression on B cells was transient. Purified B cells did not express CTLA-4 when mitogenically activated with alpha IgM and CD40 Ab, but did express the molecule when cultured in the presence of membranes from activated T cells, which suggests that induction of CTLA-4 expression on B cells was dependent on direct cell-cell contact of B lymphocytes and activated T cells. CTLA-4 molecules isolated from either T or B cells were biochemically indistinguishable. Moreover, because the ability of chimeric B7-1/Ig proteins to bind to activated B cells was correlated with CTLA-4 expression levels on these cells, we conclude that B cell-expressed CTLA-4 has ligand binding capacity. These data suggest that costimulatory receptors and their specific ligands not only play a role in T cell stimulation, but contribute in a direct fashion to the regulation of B cell responses.

This article has been cited by other articles:

				D. Quandt, H. Hoff, M. Rudolph, S. Fillatreau, and M. C. Brunner-Weinzierl A New Role of CTLA-4 on B Cells in Thymus-Dependent Immune Responses In Vivo J. Immunol., December 1, 2007; 179(11): 7316 - 7324. [Abstract] [Full Text] [PDF]

				M. Boudewijns, A. Jeurissen, M. Wuyts, L. Moens, L. Boon, J. J. Van Neerven, A. Kasran, L. Overbergh, C. Lenaerts, M. Waer, et al. Blockade of CTLA-4 (CD152) enhances the murine antibody response to pneumococcal capsular polysaccharides J. Leukoc. Biol., November 1, 2005; 78(5): 1060 - 1069. [Abstract] [Full Text] [PDF]

				A. Merlo, C. Tenca, F. Fais, L. Battini, E. Ciccone, C. E. Grossi, and D. Saverino Inhibitory Receptors CD85j, LAIR-1, and CD152 Down-Regulate Immunoglobulin and Cytokine Production by Human B Lymphocytes Clin. Vaccine Immunol., June 1, 2005; 12(6): 705 - 712. [Abstract] [Full Text] [PDF]

				M. P. Pistillo, P. L. Tazzari, G. L. Palmisano, I. Pierri, A. Bolognesi, F. Ferlito, P. Capanni, L. Polito, M. Ratta, S. Pileri, et al. CTLA-4 is not restricted to the lymphoid cell lineage and can function as a target molecule for apoptosis induction of leukemic cells Blood, January 1, 2003; 101(1): 202 - 209. [Abstract] [Full Text] [PDF]

				P. Trzonkowski, J. Mysliwska, A. Debska-Slizien, E. Bryl, D. Rachon, A. Mysliwski, and B. Rutkowski Long-term therapy with recombinant human erythropoietin decreases percentage of CD152+ lymphocytes in primary glomerulonephritis haemodialysis patients Nephrol. Dial. Transplant., June 1, 2002; 17(6): 1070 - 1080. [Abstract] [Full Text] [PDF]

				P.-L. Tazzari, L. Polito, A. Bolognesi, M.-P. Pistillo, P. Capanni, G. L. Palmisano, R. M. Lemoli, A. Curti, L. Biancone, G. Camussi, et al. Immunotoxins Containing Recombinant Anti-CTLA-4 Single-Chain Fragment Variable Antibodies and Saporin: In Vitro Results and In Vivo Effects in an Acute Rejection Model J. Immunol., October 15, 2001; 167(8): 4222 - 4229. [Abstract] [Full Text] [PDF]

				C. Pioli, L. Gatta, V. Ubaldi, and G. Doria Inhibition of IgG1 and IgE Production by Stimulation of the B Cell CTLA-4 Receptor J. Immunol., November 15, 2000; 165(10): 5530 - 5536. [Abstract] [Full Text] [PDF]

				J. O. Brubaker, Q. Li, A. O. Tzianabos, D. L. Kasper, and R. W. Finberg Mitogenic Activity of Purified Capsular Polysaccharide A from Bacteroides fragilis: Differential Stimulatory Effect on Mouse and Rat Lymphocytes In Vitro J. Immunol., February 15, 1999; 162(4): 2235 - 2242. [Abstract] [Full Text] [PDF]

				J. H. Horspool, P. J. Perrin, J. B. Woodcock, J. H. Cox, C. L. King, C. H. June, D. M. Harlan, D. C. St. Louis, and K. P. Lee Nucleic Acid Vaccine-Induced Immune Responses Require CD28 Costimulation and Are Regulated by CTLA4 J. Immunol., March 15, 1998; 160(6): 2706 - 2714. [Abstract] [Full Text] [PDF]

				P. Jeannin, Y. Delneste, S. Lecoanet-Henchoz, J.-F. Gauchat, J. Ellis, and J.-Y. Bonnefoy CD86 (B7-2) on Human B Cells. A FUNCTIONAL ROLE IN PROLIFERATION AND SELECTIVE DIFFERENTIATION INTO IgE- AND IgG4-PRODUCING CELLS J. Biol. Chem., June 20, 1997; 272(25): 15613 - 15619. [Abstract] [Full Text] [PDF]